Back

AZALEA–TIMI 71 trial: less bleeding with abelacimab compared to rivaroxaban in atrial fibrillation, but stroke prevention is uncertain

European Heart Journal - Cardiovascular Pharmacotherapy

10 March 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY

Contributors

Felice Gragnano
Felice Gragnano

Author

The University of Campania Luigi Vanvitelli Caserta , Italy

Arturo Cesaro
Arturo Cesaro

Author

Mattia Galli
Mattia Galli

Author

Paolo Calabrò
Paolo Calabrò

Author

Hospital Sant'anna E San Sebastiano Caserta , Italy

You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Congress Presentation
Medical treatment works! Contemporary implementation into clinical practice
thumbnail
Congress Presentation
The cardiovascular polypill: simplicity to tackle a complex problem

ESC 365 is supported by

novartis Explore sponsored resources